CD19 Mouse Monoclonal Antibody [Clone ID: OTI3G7]
CAT#: TA506234
CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7)
Formulation: Carrier-Free
View other "OTI3G7" antibodies (5)
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 1999.00
CNY 2700.00
| Cited in 1 publication. | 
                                                
                                                
                                                
                                                    CNY 300.00 
                                                    
                                                    CNY 1430.00
                                                
                                            
Specifications
| Product Data | |
| Clone Name | OTI3G7 | 
| Applications | FC, IF, IHC, WB | 
| Recommend Dilution | WB 1:4000, IHC 1:150, IF 1:100, FLOW 1:50 | 
| Reactivity | Human | 
| Host | Mouse | 
| Clonality | Monoclonal | 
| Immunogen | Full length human recombinant protein of human CD19(NP_001761) produced in HEK293T cell. | 
| Isotype | IgG1 | 
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. | 
| Concentration | 1 mg/ml | 
| Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C as received. | 
| Predicted Protein Size | 60.9 kDa | 
| Gene Name | CD19 molecule | 
| Database Link | |
| Background | Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq, Jul 2008] | 
| Synonyms | B4; CVID3 | 
| Reference Data | |
| Protein Families | Druggable Genome, Transmembrane | 
| Protein Pathways | B cell receptor signaling pathway, Hematopoietic cell lineage, Primary immunodeficiency | 
Citations (1)
| The use of this Antibodies has been cited in the following citations: | 
|---|
| CD19 alterations emerging after CD19-directed immunotherapy cause retention of the misfolded protein in the endoplasmic reticulum
                                                ,Bagashev, A;Sotillo, E;Tang, CA;Black, KL;Perazzelli, J;Seeholzer, SH;Argon, Y;Barrett, DM;Grupp, SA;Hu, CA;Thomas-Tikhonenko, A;,
                                                Mol. Cell. Biol.
                                                ,PubMed ID 30104252
                                                [CD19] | 
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
Other Versions
| SKU | Description | Size | Price | 
|---|---|---|---|
| CF506234 | Carrier-free (BSA/glycerol-free) CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7) | CNY 3999.00 | |
| TA506234AM | CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7), Biotinylated | CNY 3990.00 | |
| TA506234BM | CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7), HRP conjugated | CNY 3990.00 | |
| TA506234S | CD19 mouse monoclonal antibody, clone OTI3G7 (formerly 3G7) | CNY 800.00 | |
| TA600283 | CD19 mouse monoclonal capture antibody, validated for Luminex assays | 
                                                        
                                                        
                                                        
                                                            CNY 2600.00 | 

 
	
 
                         
                             
                             
                            
 
        